View the MAXRON 0.4 MG registration information details.
Back to drug list
ItemsDrug Registration information
ID2853
No2853
Brand NameMAXRON 0.4 MG
IngredientsTAMSULOSIN HYDROCHLORIDE EQ.TO TAMSULOSIN 0.4 MG
Dosage FormCAPSULE
Primary PackagingALU-ALU BLISTERPACK
Storage
Shelf Life2 YEARS
Pack Size2 X 5'S/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF MODERATE TO SEVERE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA(BPH), REDUCTION IN THE RISK OF ACUTE URINARY RETENTION AND SURGERY IN PATIENTS WITH MODERATE TO SEVERE SYMPTOM OF BPH.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE PELLETS FILLED IN CAPSULE SHELL WITH TRANSPARENT BODY AND REDDISH BROWN CAP
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerWILSHIRE LABORATORIES(PVT) LTD
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 I 4623/18
FDD Registration Date26/09/2022
Expiry Date25/09/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA